...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline
Reply New Message
Prev Message Back To Forum Threaded View Next Message

RVXOT, seeing that (OTCMKTS: RVXCF) trades on the OTC market and posted on the RVX page to the right-hand column, of the Resverlogix hub, why can't Agoracom similarly post the SPP for ZHCLF (Zenith)?

According to the MD&A, as of December 21, 2020, the number of Common Shares outstanding = 135,020,827.

At a US $0.40 closing SPP,  the market cap for Zenith is US $54 Mil +.

 

Koo

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply